Finkelstein Thompson LLP Announces Investigation of Odyssey HealthCare, Inc.
26 Mayo 2010 - 10:40AM
Business Wire
Finkelstein Thompson LLP is investigating potential claims on
behalf of shareholders of Odyssey HealthCare, Inc, (“Odyssey” or
the “Company”) (NASDAQ:ODSY) arising out of its agreement to be
acquired by Gentiva Health Services, Inc. (“Gentiva”)
(NASDAQ:GTIV). Under the terms of the merger agreement, Odyssey
shareholders will receive $27 in cash for each share of common
stock owned, valuing the transaction at approximately $1 billion.
The deal is expected to close in the third quarter of 2010.
The investigation is focused on the potential unfairness of the
consideration to Odyssey shareholders and the process by which the
Odyssey Board of Directors considered and approved the transaction.
Odyssey’s year-end financial results showed significant improvement
from the prior year and their first quarter earnings per share for
2010 beat analyst’s estimates.
If you are interested in discussing your rights as an Odyssey
shareholder, or have information relating to this investigation,
please contact Finkelstein Thompson's Washington, DC offices at
(877) 337-1050 or by email at contact@finkelsteinthompson.com.
Finkelstein Thompson LLP has spent over three decades delivering
outstanding representation to institutional and individual clients
in financial litigation, and has been appointed as lead or co-lead
counsel in dozens of shareholder class actions. Indeed, the firm
has served in leadership roles in cases that have recovered over $1
billion for investors and consumers.
To learn more about Finkelstein Thompson LLP, please visit our
web site at www.finkelsteinthompson.com. Attorney
advertising. Prior results do not guarantee similar outcomes.
Odyssey Healthcare (MM) (NASDAQ:ODSY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Odyssey Healthcare (MM) (NASDAQ:ODSY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Odyssey Healthcare (MM) (NASDAQ): 0 recent articles
Más de Finkelstein Thompson LLP Artículos de Noticias